As pharma supply chains push for efficiency and resiliency during the Covid-19 pandemic, this exclusive report created in partnership with Pharma Logistics IQ offers strategies to boost pharma’s business case for supply chain transparency

Pharma logistics leaders often struggle to build business cases for adopting supply chain transparency solutions, particularly with constrained budgets, despite a growing acceptance that enhanced supply chain transparency strengthens resiliency within the pharma supply chain.


Inside this report:

  • Industry analysis of pharma’s supply chain operational efficiency and service excellence.
  • Strategies to boost pharma’s business case for supply chain transparency.
  • Solutions to overcome pharma’s most dominant challenges for improving supply chain transparency including budget constraints, data management, and limited IT infrastructure.